EUROPE DEVICE GUIDE > Self-Expanding Stent Grafts

Company Name Product Name Materials Used Introducer Size (F) Endhole (inch) Stent Diameter (mm) Stent Length (mm) Delivery System Length (cm) CE Indication Footnotes
AndraTec GmbH Germany I-Flex Nitinol* 5, 6 0.018, 0.035 5–10 20–200 80, 130 Peripheral *Fine mesh, highly flexible, nitinol stent construction
Bard Peripheral Vascular, Inc. Covera AV Nitinol and ePTFE covered stent 8, 9 0.035 6–10 30, 40, 60, 80, 100 80 Indicated for the treatment of stenoses in the upper extremity venous outflow of patients dialyzing with an AV access graft or fistula
Bard Peripheral Vascular, Inc. Covera Plus Nitinol 8, 9 0.035 6–10 30, 40, 60, 80, 100 80, 120 Indicated for the treatment of stenoses in the upper extremity venous outflow of patients dialyzing with an AV access graft or fistula and for the treatment of atherosclerotic lesions in iliac and femoral arteries with a reference vessel diameter of 4.5 to 9 mm
Bard Peripheral Vascular, Inc. Fluency Plus Nitinol/ePTFE 8–10 0.035 5–10, 12, 13.5 20, 30, 40, 50, 60, 80, 100, 120 80, 117 Residual stenosis with impaired perfusion (pressure gradient) after balloon dilatation, especially in stages III and IV according to Fontaine; dissection; detached arteriosclerotic plaque material and luminal obstruction after balloon dilatation; occlusion after thrombolysis or after aspiration and before dilatation; restenosis or reocclusion
Boston Scientific Corporation Wallgraft Endoprosthesis With Unistep Plus Delivery System Superalloy wire/polyethylene terephthalate graft material 9–12 0.035 6–10, 12, 14 20, 30, 50, 70 Indicated for use for treatment of complex iliac artery stenoses (lesions ≥ 3 cm in length or a calcified or eccentric lesions < 3 cm in length) and iliac occlusions in vessels 7–12 mm in diameter; the exclusion of atherosclerotic arterial aneurysms and traumatic vessel disruptions in peripheral vessels 5–12 mm in diameter
Gore & Associates Gore Viabahn Endoprosthesis Nitinol/ePTFE, gold 7–12 0.035 5, 6, 7, 8, 9, 10, 11, 13 25, 50, 100, 150 75, 120 The endovascular grafting of peripheral arteries and improving blood flow in the symptomatic obstruction of peripheral veins
Gore & Associates Gore Viabahn Endoprosthesis With Propaten Bioactive Surface Nitinol/ePTFE, gold 6–12 0.018/0.014 (5–8 mm), 0.035 (5–13 mm) 5, 6, 7, 8, 9, 10, 11, 13 25, 50, 100, 150, 250 75 (0.035-inch system only), 120 The endovascular grafting of peripheral arteries and improving blood flow in the symptomatic obstruction of peripheral veins
Gore & Associates Gore Viabil Biliary Endoprosthesis Nitinol/ePTFE 10 percutaneous, 8.5 endoscopic 0.035 8, 10 40, 60, 80, 100 40 percutaneous, 200 endoscopic Malignant biliary strictures* *Contraindicated for all cardiovascular applications
Gore & Associates Gore Viatorr TIPS Endoprosthesis Nitinol/ePTFE 10 0.038 8, 10, 12 60, 70, 80, 90, 100 75 TIPS, tracheobronchial

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.